Document is current
Any future updates will be listed below
-
Authors
Chaib, Selim https://orcid.org/0000-0003-0497-2002
Palmer, Allyson K.
Wyles, Saranya P. https://orcid.org/0000-0002-0406-7427
Musi, Nicolas
Kirkland, James L. https://orcid.org/0000-0003-1676-4905
Tchkonia, Tamara https://orcid.org/0000-0003-4623-7145
- License Information
-
More Information
Article History
Accepted: 11 September 2025
First Online: 6 October 2025
Competing interests
: T.T., A.K.P. and J.L.K. have a financial interest related to this article, including patents and pending patents covering senolytic drugs and their uses. S.C. holds patents or pending patents on PDL2 at Mayo Clinic and Spanish National Cancer Research Center, some of which have been licensed to Rejuveron Senescence Therapeutics. The other authors declare no competing interests.
